Concepedia

Behrad Darvishi

BD

Statistics

Publications

18

Citations

613

H-Index

13

Active since

2012

Affiliations

Tehran University of Medical Sciences(Current)

Motamed Cancer Institute

Academic Center for Education, Culture and Research

University of Tehran

Iran University of Medical Sciences

Behrad Darvishi is an author at Tehran University of Medical Sciences specializing in pharmacy, nanomedicine, and pharmacology.

ORCID

Publications per year

2012–2021

18

Publications

18

Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel

Saeed Manoochehri, Behrad Darvishi, Golnaz Kamalinia et al. · DARU Journal of Pharmaceutical Sciences · 2013 · 123 citations · Full text

, , +17

Paclitaxel molecularly imprinted polymer-PEG-folate nanoparticles for targeting anticancer delivery: Characterization and cellular cytotoxicity

Mehdi Esfandyari‐Manesh, Behrad Darvishi, Fatemeh Azizi Ishkuh et al. · Materials Science and Engineering C · 2016 · 88 citations

, , +16

Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles

Mehdi Esfandyari‐Manesh, Seyed Hossein Mostafavi, Reza Faridi‐Majidi et al. · DARU Journal of Pharmaceutical Sciences · 2015 · 53 citations · Full text

, , +17

Interferons: role in cancer therapy

Mohadeseh Haji Abdolvahab, Behrad Darvishi, Mohammad Zarei et al. · Immunotherapy · 2020 · 51 citations

, , +16

Pegylated magnetic mesoporous silica nanoparticles decorated with AS1411 Aptamer as a targeting delivery system for cytotoxic agents

Ramin Sakhtianchi, Behrad Darvishi, Zahra Mirzaie et al. · Pharmaceutical Development and Technology · 2019 · 48 citations

, , +17

1–5 of 18